Skip to main content
Erschienen in: Endocrine 2/2023

07.10.2022 | Original Article

Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis

verfasst von: Lei Yin, Shuang Hou, Li-Li Hou, Chen-Chen Pu

Erschienen in: Endocrine | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Insular thyroid carcinoma (ITC) is an uncommon poorly differentiated thyroid malignancy. Due to its rarity, its demographic and clinicopathological features and survival remains unclear. The present study aimed to describe the features and survival of ITC, determine its prognostic factors, and establish a prognostic nomogram.

Methods

Patients with ITC were identified in the Surveillance, Epidemiology, and End Results database from 2004 to 2019. The features and survival of patients with ITC and other thyroid carcinomas were compared after balancing the baseline characteristics using propensity score matching (PSM). Univariate and multivariate Cox analyses were used to identify the prognostic factors for ITC. Moreover, overall survival (OS)- or cancer-specific survival (CSS)-specific nomograms were established to predict ITC prognosis.

Results

A total of 206 patients with ITCs were identified. The 1-, 2-, 5-, and 10-year OS rates of 206 patients with ITC were 90.3%, 82.0%, 62.2%, and 42.5%, respectively. The median OS was 93 months (95% CI, 73.0–140.0), while the median CSS was 141 months (95% CI, 93.0–173.0). After PSM analysis, the survival analysis of the matched cohort revealed that ITC had a worse clinical outcome than papillary thyroid cancer and follicular thyroid cancer, and better survival than anaplastic thyroid carcinoma. Multivariate Cox regression analysis demonstrated that age, N stage, M stage, and surgery were independent prognostic factors for both OS and CSS in ITC patients. The C-indices for the OS- and CSS-specific nomograms were 0.778 (95% CI, 0.724–0.832) and 0.808 (95% CI, 0.754–0.862), respectively. The calibration curve and ROC analysis indicated that the nomogram models exhibited a good discriminative ability. Decision curve analysis suggested that the nomogram models had a significant positive net benefit and were better than the traditional TNM staging system at predicting survival.

Conclusion

ITC has distinct clinicopathological characteristics and survival compared to other thyroid carcinomas, and the established nomogram could predict the survival probability of patients with ITC accurately with a higher net benefit.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)CrossRef American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)CrossRef
2.
Zurück zum Zitat M.L. Carcangiu, G. Zampi, J. Rosai, Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am. J. Surg. Pathol. 8(9), 655–668 (1984)CrossRef M.L. Carcangiu, G. Zampi, J. Rosai, Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am. J. Surg. Pathol. 8(9), 655–668 (1984)CrossRef
3.
Zurück zum Zitat Z.W. Baloch, S.L. Asa, J.A. Barletta, R.A. Ghossein, C.C. Juhlin, C.K. Jung et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33(1), 27–63 (2022)CrossRef Z.W. Baloch, S.L. Asa, J.A. Barletta, R.A. Ghossein, C.C. Juhlin, C.K. Jung et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33(1), 27–63 (2022)CrossRef
4.
Zurück zum Zitat D. Hiltzik, D.L. Carlson, R.M. Tuttle, S. Chuai, N. Ishill, A. Shaha et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106(6), 1286–1295 (2006)CrossRef D. Hiltzik, D.L. Carlson, R.M. Tuttle, S. Chuai, N. Ishill, A. Shaha et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106(6), 1286–1295 (2006)CrossRef
5.
Zurück zum Zitat R. Hod, G. Bachar, Y. Sternov, J. Shvero, Insular thyroid carcinoma: a retrospective clinicopathologic study. Am. J. Otolaryngol. 34(4), 292–295 (2013)CrossRef R. Hod, G. Bachar, Y. Sternov, J. Shvero, Insular thyroid carcinoma: a retrospective clinicopathologic study. Am. J. Otolaryngol. 34(4), 292–295 (2013)CrossRef
6.
Zurück zum Zitat M.I. Bellini, M. Biffoni, R. Patrone, M.C. Borcea, M.L. Costanzo, T. Garritano et al. Poorly differentiated thyroid carcinoma: single centre experience and review of the literature. J. Clin. Med. 10(22), 5258 (2021)CrossRef M.I. Bellini, M. Biffoni, R. Patrone, M.C. Borcea, M.L. Costanzo, T. Garritano et al. Poorly differentiated thyroid carcinoma: single centre experience and review of the literature. J. Clin. Med. 10(22), 5258 (2021)CrossRef
7.
Zurück zum Zitat K.Y. Lam, C.Y. Lo, K.W. Chan, K.Y. Wan, Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann. Surg. 231(3), 329–338 (2000)CrossRef K.Y. Lam, C.Y. Lo, K.W. Chan, K.Y. Wan, Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann. Surg. 231(3), 329–338 (2000)CrossRef
8.
Zurück zum Zitat L. Liu, D. Li, H. Wang, X. Yang, Y. Yu, M. Gao, Multifocality predicts poor outcome of patients with insular thyroid cancer: a clinicopathological study. Int J. Clin. Exp. Pathol. 8(9), 11212–11217 (2015) L. Liu, D. Li, H. Wang, X. Yang, Y. Yu, M. Gao, Multifocality predicts poor outcome of patients with insular thyroid cancer: a clinicopathological study. Int J. Clin. Exp. Pathol. 8(9), 11212–11217 (2015)
9.
Zurück zum Zitat D.Y. Lee, J.K. Won, S.H. Lee, D.J. Park, K.C. Jung, M.W. Sung et al. Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma. Thyroid 26(3), 404–413 (2016)CrossRef D.Y. Lee, J.K. Won, S.H. Lee, D.J. Park, K.C. Jung, M.W. Sung et al. Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma. Thyroid 26(3), 404–413 (2016)CrossRef
10.
Zurück zum Zitat T.A. Pezzi, V.C. Sandulache, C.M. Pezzi, A.E. Turkeltaub, L. Feng, M.E. Cabanillas et al. Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base. Head Neck 38(6), 906–912 (2016)CrossRef T.A. Pezzi, V.C. Sandulache, C.M. Pezzi, A.E. Turkeltaub, L. Feng, M.E. Cabanillas et al. Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base. Head Neck 38(6), 906–912 (2016)CrossRef
11.
Zurück zum Zitat T.C. Chao, J.D. Lin, M.F. Chen, Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J. Surg. 28(4), 393–396 (2004)CrossRef T.C. Chao, J.D. Lin, M.F. Chen, Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J. Surg. 28(4), 393–396 (2004)CrossRef
12.
Zurück zum Zitat R. Ashfaq, F. Vuitch, R. Delgado, J. Albores-Saavedra, Papillary and follicular thyroid carcinomas with an insular component. Cancer 73(2), 416–423 (1994)CrossRef R. Ashfaq, F. Vuitch, R. Delgado, J. Albores-Saavedra, Papillary and follicular thyroid carcinomas with an insular component. Cancer 73(2), 416–423 (1994)CrossRef
13.
Zurück zum Zitat M. Papotti, F. Botto Micca, A. Favero, N. Palestini, G. Bussolati, Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns [J]. Am. J. Surg. Pathol. 17(3), 291–301 (1993)CrossRef M. Papotti, F. Botto Micca, A. Favero, N. Palestini, G. Bussolati, Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns [J]. Am. J. Surg. Pathol. 17(3), 291–301 (1993)CrossRef
14.
Zurück zum Zitat G. Pellegriti, D. Giuffrida, C. Scollo, R. Vigneri, C. Regalbuto, S. Squatrito et al. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer 95(10), 2076–2085 (2002)CrossRef G. Pellegriti, D. Giuffrida, C. Scollo, R. Vigneri, C. Regalbuto, S. Squatrito et al. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer 95(10), 2076–2085 (2002)CrossRef
15.
Zurück zum Zitat M.W. van den Brekel, R.J. Hekkenberg, S.L. Asa, G. Tomlinson, I.B. Rosen, J.L. Freeman, Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 107(2), 254–259 (1997)CrossRef M.W. van den Brekel, R.J. Hekkenberg, S.L. Asa, G. Tomlinson, I.B. Rosen, J.L. Freeman, Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 107(2), 254–259 (1997)CrossRef
16.
Zurück zum Zitat P.O. Kiratli, P.P. Kara, E.L. Ergun, G. Gedikoglu, Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents. Ann. Nucl. Med 18(5), 443–446 (2004)CrossRef P.O. Kiratli, P.P. Kara, E.L. Ergun, G. Gedikoglu, Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents. Ann. Nucl. Med 18(5), 443–446 (2004)CrossRef
17.
Zurück zum Zitat V. Rufini, M. Salvatori, G. Fadda, L. Pinnarelli, P. Castaldi, M.L. Maussier et al. Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 110(6), 1209–1217 (2007)CrossRef V. Rufini, M. Salvatori, G. Fadda, L. Pinnarelli, P. Castaldi, M.L. Maussier et al. Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 110(6), 1209–1217 (2007)CrossRef
18.
Zurück zum Zitat M. Sywak, J.L. Pasieka, T. Ogilvie, A review of thyroid cancer with intermediate differentiation. J. Surg. Oncol. 86(1), 44–54 (2004)CrossRef M. Sywak, J.L. Pasieka, T. Ogilvie, A review of thyroid cancer with intermediate differentiation. J. Surg. Oncol. 86(1), 44–54 (2004)CrossRef
19.
Zurück zum Zitat A.S. Ho, M. Luu, L. Barrios, I. Chen, M. Melany, N. Ali et al. Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma. JAMA Oncol. 6(5), 706–713 (2020)CrossRef A.S. Ho, M. Luu, L. Barrios, I. Chen, M. Melany, N. Ali et al. Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma. JAMA Oncol. 6(5), 706–713 (2020)CrossRef
20.
Zurück zum Zitat S. Jin, X. Liu, D. Peng, D. Li, Y.N. Ye, Differences between cancer-specific survival of patients with anaplastic and primary squamous cell thyroid carcinoma and factors influencing prognosis: a SEER database analysis. Front Endocrinol. 13, 830760 (2022)CrossRef S. Jin, X. Liu, D. Peng, D. Li, Y.N. Ye, Differences between cancer-specific survival of patients with anaplastic and primary squamous cell thyroid carcinoma and factors influencing prognosis: a SEER database analysis. Front Endocrinol. 13, 830760 (2022)CrossRef
21.
Zurück zum Zitat T. Ibrahimpasic, R. Ghossein, J.P. Shah, I. Ganly, Poorly differentiated carcinoma of the thyroid gland: current status and future prospects. Thyroid 29(3), 311–21. (2019)CrossRef T. Ibrahimpasic, R. Ghossein, J.P. Shah, I. Ganly, Poorly differentiated carcinoma of the thyroid gland: current status and future prospects. Thyroid 29(3), 311–21. (2019)CrossRef
22.
Zurück zum Zitat Y. Liu, Z. Liu, Q. Zhao, T. Hua, S. Chi, T. Huang et al. Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database. Oncotarget 8(60), 101623–33. (2017)CrossRef Y. Liu, Z. Liu, Q. Zhao, T. Hua, S. Chi, T. Huang et al. Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database. Oncotarget 8(60), 101623–33. (2017)CrossRef
23.
Zurück zum Zitat M. Bongiovanni, P.M. Sadow, W.C. Faquin, Poorly differentiated thyroid carcinoma: a cytologic-histologic review. Adv. Anat. Pathol. 16(5), 283–289 (2009)CrossRef M. Bongiovanni, P.M. Sadow, W.C. Faquin, Poorly differentiated thyroid carcinoma: a cytologic-histologic review. Adv. Anat. Pathol. 16(5), 283–289 (2009)CrossRef
24.
Zurück zum Zitat M. Decaussin, M.H. Bernard, P. Adeleine, I. Treilleux, J.L. Peix, M. Pugeat et al. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component. Am. J. Surg. Pathol. 26(8), 1007–1015 (2002)CrossRef M. Decaussin, M.H. Bernard, P. Adeleine, I. Treilleux, J.L. Peix, M. Pugeat et al. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component. Am. J. Surg. Pathol. 26(8), 1007–1015 (2002)CrossRef
25.
Zurück zum Zitat A. Sasaki, T. Daa, K. Kashima, S. Yokoyama, I. Nakayama, S. Noguchi, Insular component as a risk factor of thyroid carcinoma. Pathol. Int 46(12), 939–946 (1996)CrossRef A. Sasaki, T. Daa, K. Kashima, S. Yokoyama, I. Nakayama, S. Noguchi, Insular component as a risk factor of thyroid carcinoma. Pathol. Int 46(12), 939–946 (1996)CrossRef
26.
Zurück zum Zitat S. Roman, J.A. Sosa, Aggressive variants of papillary thyroid cancer. Curr. Opin. Oncol. 25(1), 33–38 (2013)CrossRef S. Roman, J.A. Sosa, Aggressive variants of papillary thyroid cancer. Curr. Opin. Oncol. 25(1), 33–38 (2013)CrossRef
Metadaten
Titel
Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis
verfasst von
Lei Yin
Shuang Hou
Li-Li Hou
Chen-Chen Pu
Publikationsdatum
07.10.2022
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03200-x

Weitere Artikel der Ausgabe 2/2023

Endocrine 2/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.